Blood eosinophils and mortality in patients with acute respiratory distress syndrome: A propensity score matching analysis

doi:10.5847/wjem.j.1920-8642.2021.02.008

Abstract

Abstract:

BACKGROUND: The effect of blood eosinophils (EOSs) on mortality in acute respiratory distress syndrome (ARDS) patients and whether corticosteroids affect this effect are unclear.

METHODS: The Medical Information Mart for Intensive Care III database (version 1.4) was used to extract data. Patients with ARDS were selected for inclusion. Cox regression models using the backward stepwise method and propensity score matching (PSM) were used to assess the relationship between blood EOS counts and 28-day mortality.

RESULTS: A total of 2,567 patients with ARDS were included, and the 28-day mortality rate was 24.19%. The crude 28-day mortality was significantly lower in patients with EOS counts ≥2% (18.60% [85/457] vs. 25.40% [536/2,110], P=0.002) than in those with EOS counts <2%. In the Cox regression model, the EOS counts ≥2% showed a significant association with the decreased 28-day mortality (hazard ratio [HR] 0.731; 95% confidence interval [95% CI] 0.581-0.921, P=0.008). In the corticosteroid non-use subgroup, EOS counts ≥2% was significantly related to decreased 28-day mortality (HR 0.697, 95% CI 0.535-0.909, P=0.008), but the result was not significant in the corticosteroid non-use subgroup model (P=0.860). A total of 457 well-matched pairs were obtained by a 1:1 matching algorithm after PSM. The 28-day mortality remained significantly lower in the EOS counts ≥2% group (18.60% [85/457] vs. 26.70% [122/457], P=0.003).

CONCLUSIONS: Higher EOS counts are related to lower 28-day mortality in ARDS patients, and this relationship can be counteracted by using corticosteroids.

Key words: Critical care, Acute respiratory distress syndrome, Eosinophils, Mortality, Corticosteroid

Hao-tian Chen, Jian-feng Xu, Xiao-xia Huang, Ni-ya Zhou, Yong-kui Wang, Yue Mao. Blood eosinophils and mortality in patients with acute respiratory distress syndrome: A propensity score matching analysis[J]. World Journal of Emergency Medicine, 2021, 12(2): 131-136.

Figures/Tables 4

Table 1

Comparisons of baseline characteristics between survivors and non-survivors

Variables	Total (n=2,567)	Survivors (n=1,946)	Non-survivors (n=621)	P
Age (years)	63.35 (51.39-75.98)	62.14 (50.38-74.55)	68.02 (55.20-79.44)	<0.001
Male, n (%)	1,479 (57.62)	1,127 (57.91)	352 (56.68)	0.589
Weight (kg)	81.1 (68.0-97.1)	82.3 (70.0-98.2)	77.9 (64.1-92.3)	<0.001
BMI (kg/m²)	27.91 (24.13-32.91)	28.23 (24.41-33.09)	27.08 (22.79-31.98)	<0.001
Heart rate (beats per minute)	88.37 (78.89-98.47)	88.05(78.96-97.69)	89.68 (78.90-100.89)	0.028
MAP (mmHg)	77.25 (71.92-84.17)	77.79 (72.30-84.17)	75.85 (70.74-84.51)	0.073
PaO₂/FiO₂ ratio	237.83 (193.89-289.95)	239.17 (194.67-291.77)	232.50 (191.42-279.47)	<0.001
Comorbidities, n (%)
Diabetes	728 (28.36)	562 (28.88)	166 (26.73)	0.301
Sepsis	1,584 (61.71)	1,165 (59.87)	419 (67.47)	0.001
Severity of illness
SAPS II	44 (35-55)	42 (33-52)	53(44-64)	<0.001
ARDS severity, n (%)
Mild	379 (14.76)	305 (15.67)	74 (11.92)	<0.001
Moderate	1,023 (39.85)	816 (41.93)	207 (33.33)
Severe	1,165 (45.38)	825 (42.39)	340 (54.75)
Laboratory data
WBC (×10⁹/L)	12.8 (8.8-18.1)	12.5 (8.8-17.5)	14.0 (8.9-19.4)	0.003
RBC (×10⁹/L)	3.58 (3.10-4.10)	3.59 (3.11-4.11)	3.54 (3.06-4.07)	0.133
PLT (×10⁹/L)	201 (139-276)	202 (144-270)	197 (118-294)	0.056
Lactate (mmol/L)	2.1 (1.4-2.7)	2.0 (1.3-2.5)	2.5 (1.7-3.8)	<0.001
EOS counts initial (×10⁹/L)	0.2 (0-1.0)	0.3 (0-1.0)	0.1 (0-0.6)	<0.001
EOS counts minimum (×10⁹/L)	0.2 (0-0.9)	0.2 (0-1.0)	0.1 (0-0.4)	<0.001
EOS counts maximum (×10⁹/L)	0.4 (0-1.2)	0.5 (0.1-1.3)	0.2 (0-1.0)	<0.001
pH	7.35 (7.28-7.42)	7.36 (7.29-7.42)	7.33 (7.26-7.41)	<0.001
Mechanical ventilation
Tidal volume (mL/kg PBW)	6.65 (5.41-8.04)	6.56 (5.35-7.95)	6.85 (5.63-8.21)	0.001
Minute ventilation (L/min)	9.8 (8.0-12.4)	9.6 (7.9-12.0)	10.4 (8.3-13.8)	<0.001
Low tidal volume, n (%)	1,167 (45.46)	910 (46.76)	257 (41.38)	0.019
Drug usage, n (%)
Corticosteroid use	436 (16.98)	276 (14.18)	160 (25.76)	<0.001
Vasopressor use
No vasopressor	1,765 (68.76)	1,442 (74.10)	323 (52.01)	<0.001
One vasopressor	512 (19.95)	338 (17.37)	174 (28.02)
Two vasopressors	290 (11.30)	166 (8.53)	124 (19.97)
Antibiotics use	2,208 (86.01)	1,677 (86.18)	531 (85.51)	0.308

Table 1

Table 2

Figure 1.

Table 3

References 24

1	Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A , et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016; 315(8):788-800. doi: 10.1001/jama.2016.0291 pmid: 26903337
2	Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A , et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019; 5(1):18. doi: 10.1038/s41572-019-0069-0 pmid: 30872586
3	Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D , et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset.[J] Clin Invest. 2016; 126(9):3279-95. doi: 10.1172/JCI85664
4	Wu HX, Zhuo KQ, Cheng DY . Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int[J] Chron Obstruct Pulmon Dis. 2019; 14:3003-15.
5	Oh YM, Lee KS, Hong Y, Hwang SC, Kim JY, Kim DK , et al. Blood eosinophil count as a prognostic biomarker in COPD. Int[J] Chron Obstruct Pulmon Dis. 2018; 13:3589-96.
6	Håkansson KEJ, Rasmussen LJH, Godtfredsen NS, Tupper OD, Eugen-Olsen J, Kallemose T , et al. The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study. Respir Res. 2019; 20(1):258. doi: 10.1186/s12931-019-1234-4 pmid: 31730462
7	Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M , et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015; 3(11):849-58. doi: 10.1016/S2213-2600(15)00367-7 pmid: 26493938
8	Global strategy for the diagnosis, management, prevention of COPD update 2019. Available at https://goldcopd.org/.
9	Modig J, Samuelsson T, Hällgren R . The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation. 1986; 14(3):121-34. doi: 10.1016/0300-9572(86)90116-4 pmid: 3027805
10	Hällgren R, Borg T, Venge P, Modig J . Signs of neutrophil and eosinophil activation in adult respiratory distress syndrome. Crit Care Med. 1984; 12(1):14-8. doi: 10.1097/00003246-198401000-00004 pmid: 6690198
11	Willetts L, Parker K, Wesselius LJ, Protheroe CA, Jaben E, Graziano P , et al. Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury. Respir Res. 2011; 12:116. doi: 10.1186/1465-9921-12-116 pmid: 21871108
12	Zhu C, Weng QY, Zhou LR, Cao C, Li F, Wu YF , et al. Homeostatic and early-recruited CD101 eosinophils suppress endotoxin-induced acute lung injury. Eur Respir J. 2020; 56(5):1902354. doi: 10.1183/13993003.02354-2019 pmid: 32527738
13	Chan MC, Chao WC, Liang SJ, Tseng CH, Wang HC, Chien YC , et al. First tidal volume greater than 8 mL/kg is associated with increased mortality in complicated influenza infection with acute respiratory distress syndrome.[J] Formos Med Assoc. 2019; 118(1 Pt 2):378-85.
14	Shen Y, Cai G, Gong S, Dong L, Yan J, Cai W . Interaction between low tidal volume ventilation strategy and severity of acute respiratory distress syndrome: a retrospective cohort study. Crit Care. 2019; 23(1):254. doi: 10.1186/s13054-019-2530-6 pmid: 31300012
15	Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. doi: 10.1001/jama.2012.5669 pmid: 22797452
16	Thorn GW, Renold AE, Wilson DL, Frawley TF, Jenkins D, Garcia-Reyes J , et al. Clinical studies on the activity of orally administered cortisone. N Engl[J] Med. 1951; 245(15):549-55.
17	Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT , et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am[J] Respir Crit Care Med. 2017; 195(3):331-8. doi: 10.1164/rccm.201603-0645OC
18	Mantovani A, Cassatella MA, Costantini C, Jaillon S . Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011; 11(8):519-31. doi: 10.1038/nri3024 pmid: 21785456
19	Mammen MJ, Aryal K, Alhazzani W, Alexander PE . Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. Pol Arch Intern Med. 2020; 130(4):276-86. doi: 10.20452/pamw.15239 pmid: 32186831
20	Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ , et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007; 131(4):954-63. doi: 10.1378/chest.06-2100 pmid: 17426195
21	Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A , et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017; 43(12):1751-63. doi: 10.1007/s00134-017-4919-5 pmid: 28940011
22	Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R , et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl[J] Med. 2006; 354(16):1671-84.
23	Wang YM, Zheng YJ, Chen Y, Huang YC, Chen WW, Ji R , et al. Effects of fluid balance on prognosis of acute respiratory distress syndrome patients secondary to sepsis. World[J] Emerg Med. 2020; 11(4):216-22. doi: 10.1046/j.1442-2026.1999.00072.x
24	Bafadhel M, Pavord ID, Russell REK . Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017; 5(9):747-59. doi: 10.1016/S2213-2600(17)30217-5 pmid: 28601554

Variables	Total (n=2,567)			Patients who used corticosteroids (n=436)			Patients who did not use corticosteroids (n=2,131)
Variables	EOS counts <2% (n=2,110)	EOS counts ≥2% (n=457)	P	EOS counts <2% (n=389)	EOS counts ≥2% (n=47)	P	EOS counts <2% (n=1,721)	EOS counts ≥2% (n=410)	P
28-day mortality, n (%)	536 (25.40)	85 (18.60)	0.002	139 (35.73)	21 (44.68)	0.229	397 (23.07)	64 (15.61)	0.001
ICU mortality, n (%)	448 (21.23)	71 (15.54)	0.006	125 (32.13)	22 (46.81)	0.144	323 (18.77)	49 (11.95)	0.001
Hospital mortality, n (%)	527 (24.98)	81 (17.72)	0.001	140 (35.99)	21 (44.68)	0.244	387 (22.49)	60 (14.63)	<0.001
Length of ICU stay (days)	6.17 (3.67-11.92)	6.21 (3.58-12.38)	0.918	7.29 (4.33-14.13)	7.33 (3.71-12.13)	0.538	5.96 (3.46-11.33)	6.08 (3.46-12.63)	0.629
Length of hospital stay (days)	12.00 (7.25-20.25)	11.92 (7.38-21.83)	0.340	14.17 (8.25-23.83)	12.21 (6.88-16.92)	0.094	11.75 (7.16-19.00)	11.89 (7.38-22.88)	0.392

Variables	Model 1			Model 2			Model 3
Variables	HR	95% CI	P	HR	95% CI	P	HR	95% CI	P
EOS counts	0.731	0.581-0.921	0.008	0.697	0.535-0.909	0.008	/	/	/
SAPS II	1.029	1.024-1.035	<0.001	1.032	1.026-1.038	<0.001	1.025	1.014-1.035	<0.001
Lactate	1.110	1.081-1.140	<0.001	1.111	1.077-1.147	<0.001	1.131	1.072-1.195	<0.001
Minute ventilation	1.033	1.011-1.055	0.003	1.036	1.010-1.062	0.005	/	/	/
Vasopressor use	1.288	1.159-1.431	<0.001	1.368	1.208-1.548	<0.001	/	/	/
ARDS severity	1.563	1.252-1.952	<0.001	1.787	1.497-2.134	<0.001	/	/	/
BMI	0.984	0.974-0.995	0.004	0.980	0.967-0.992	0.002	/	/	/
Age	1.002	1.001-1.004	0.003	1.002	1.001-1.004	0.003	/	/	/
PaO₂/FiO₂ ratio	0.998	0.996-0.999	0.018	/	/	/	0.991	0.988-0.993	<0.001

[1]	Yu-qing Cui, Xian-fei Ding, Huo-yan Liang, Dong Wang, Xiao-juan Zhang, Li-feng Li, Quan-cheng Kan, Le-xin Wang, Tong-wen Sun. Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2021, 12(3): 207-213.
[2]	Wen Gao, Yu-ping Zhang, Jing-fen Jin. Poor outcomes of delirium in the intensive care units are amplified by increasing age: A retrospective cohort study [J]. World Journal of Emergency Medicine, 2021, 12(2): 117-123.
[3]	Xin Lu, Wei Han, Yan-xia Gao, Shi-gong Guo, Shi-yuan Yu, Xue-zhong Yu, Hua-dong Zhu, Yi Li. Efficacy and safety of corticosteroids in immunocompetent patients with septic shock [J]. World Journal of Emergency Medicine, 2021, 12(2): 124-130.
[4]	Wei Guo, Lin-yu Ran, Ji-hong Zhu, Qing-gang Ge, Zhe Du, Fei-long Wang, Wei-bo Gao, Tian-bing Wang. Identifying critically ill patients at risk of death from coronavirus disease [J]. World Journal of Emergency Medicine, 2021, 12(1): 18-23.
[5]	Yi Han, Su-cheng Mu, Jian-li Wang, Wei Wei, Ming Zhu, Shi-lin Du, Min Min, Yun-jie Xu, Zhen-ju Song, Chao-yang Tong. MicroRNA-145 plays a role in mitochondrial dysfunction in alveolar epithelial cells in lipopolysaccharide-induced acute respiratory distress syndrome [J]. World Journal of Emergency Medicine, 2021, 12(1): 54-60.
[6]	Yu-ming Wang, Yan-jun Zheng, Ying Chen, Yun-chuan Huang, Wei-wei Chen, Ran Ji, Li-li Xu, Zhi-tao Yang, Hui-qiu Sheng, Hong-ping Qu, En-qiang Mao, Er-zhen Chen. Effects of fluid balance on prognosis of acute respiratory distress syndrome patients secondary to sepsis [J]. World Journal of Emergency Medicine, 2020, 11(4): 216-222.
[7]	Rui-xue Sun, Priscilla Song, Joseph Walline, He Wang, Ying-chun Xu, Hua-dong Zhu, Xue-zhong Yu, Jun Xu. Morbidity and mortality risk factors in emergency department patients with Acinetobacter baumannii bacteremia [J]. World Journal of Emergency Medicine, 2020, 11(3): 164-168.
[8]	Shao-hua Liu, Huo-yan Liang, Hong-yi Li, Xian-fei Ding, Tong-wen Sun, Jing Wang. Effect of low high-density lipoprotein levels on mortality of septic patients: A systematic review and meta-analysis of cohort studies [J]. World Journal of Emergency Medicine, 2020, 11(2): 109-116.
[9]	Wei He, Yue-yang You, Kai Sun, Chen Xie, Yue Ming, Li-na Yu, Feng-jiang Zhang, Min Yan. Admission delay is associated with worse surgical outcomes for elderly hip fracture patients: A retrospective observational study [J]. World Journal of Emergency Medicine, 2020, 11(1): 27-32.
[10]	Chang Pan, Xiao-ran Huang, Jiao-jiao Pang, Kai Cheng, Feng Xu, Yu-guo Chen. Trends in mortality of emergency departments patients in China [J]. World Journal of Emergency Medicine, 2019, 10(3): 152-155.
[11]	Hui Xie, Zhi-gang Zhou, Wei Jin, Cheng-bin Yuan, Jiang Du, Jian Lu, Rui-lan Wang. Ventilator management for acute respiratory distress syndrome associated with avian influenza A (H7N9) virus infection: A case series [J]. World Journal of Emergency Medicine, 2018, 9(2): 118-124.
[12]	Yuzeng Shen, Yee Chien Tay, Edward Wee Kwan Teo, Nan Liu, Shao Wei Lam, Marcus Eng Hock Ong. Association between the elderly frequent attender to the emergency department and 30-day mortality: A retrospective study over 10 years [J]. World Journal of Emergency Medicine, 2018, 9(1): 20-25.
[13]	Kasim Turgut, Mehmet Ediz Sarihan, Cemil Colak, Taner Güven, Ali Gür, Sükrü Gürbüz. Falls from height: A retrospective analysis [J]. World Journal of Emergency Medicine, 2018, 9(1): 46-50.
[14]	Youichi Yanagawa, Kouhei Ishikawa, Kei Jitsuiki, Toshihiko Yoshizawa, Yasumasa Oode, Kazuhiko Omori, Hiromichi Ohsaka. Fibrinogen degradation product levels on arrival for trauma patients requiring a transfusion even without head injury [J]. World Journal of Emergency Medicine, 2017, 8(2): 106-109.
[15]	Farideh Razban, Sedigheh Iranmanesh, Hasan Eslami Aliabadi, Mansooreh Azzizadeh Forouzi. Critical care nurses' attitude towards life-sustaining treatments in South East Iran [J]. World Journal of Emergency Medicine, 2016, 7(1): 59-64.